Fat cells are a culprit in osteoporosis
Approximately 10 million Americans have osteoporosis, also known as a silent disease due to symptoms that go unnoticed until a fracture occurs. Scientists are focused on understanding the mechanisms that contribute to the loss of bone strength, as well as developing therapies for prevention and treatment.
Weibo Hunag, Feng Hua and Tong Suand a team in China published an in the Journal of Lipid Research. They investigated the relationship between bone marrow adipocytes, or BMAds, and osteoblast bone building cells. BMAds are fat cells that reside in the bone marrow, and contribute to 10% of the total body fat and occupy 50–70% of the marrow cavity space. Their abundance has been associated with aging, postmenopausal period, obesity, radiotherapy and chemotherapy and glucocorticoid treatments.
The researchers treated bone marrow osteoblast cultures with adipocytes and observed that the adipocytes transferred lipid droplets to the osteoblasts. RNA sequencing and Western blot showed that the lipid droplet–filled osteoblasts downregulated osteopontin, a major bone-forming protein, and other osteogenic proteins. Furthermore, the lipids seemed to upregulate the ferroptosis pathway in the osteoblasts, inducing cell death, and it decreased oxidative phosphorylation, which generates cellular energy. When the researchers treated the osteoblasts with ferroptosis inhibitors, they found that impediments to the osteoblast cells were reversed.
This work shows the ferroptosis pathway and proteins such as ABHD5 as important targets for the development of effective treatments and prevention therapies for osteoporosis. Looking ahead, the researchers will conduct further investigations into the activation mechanisms of these pathways to provide a solid foundation for clinical translation.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Bacteriophage protein could make queso fresco safer
Researchers characterized the structure and function of PlyP100, a bacteriophage protein that shows promise as a food-safe antimicrobial for preventing Listeria monocytogenes growth in fresh cheeses.
Building the blueprint to block HIV
Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7鈥�10, in Maryland.
Gut microbes hijack cancer pathway in high-fat diets
Researchers at the Feinstein Institutes for Medical Research found that a high-fat diet increases ammonia-producing bacteria in the gut microbiome of mice, which in turn disrupts TGF-尾 signaling and promotes colorectal cancer.
Mapping fentanyl鈥檚 cellular footprint
Using a new imaging method, researchers at State University of New York at Buffalo traced fentanyl鈥檚 effects inside brain immune cells, revealing how the drug alters lipid droplets, pointing to new paths for addiction diagnostics.
Designing life鈥檚 building blocks with AI
Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.
Cholesterol as a novel biomarker for Fragile X syndrome
Researchers in Quebec identified lower levels of a brain cholesterol metabolite, 24-hydroxycholesterol, in patients with fragile X syndrome, a finding that could provide a simple blood-based biomarker for understanding and managing the condition.